Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma

INTRODUCTION: The objective of this study was to evaluate real-world effectiveness of latanoprostene bunod (LBN) ophthalmic solution 0.024% in treatment-naïve patients newly diagnosed with open-angle glaucoma (OAG) or ocular hypertension. METHODS: This multicenter retrospective chart review included...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ophthalmol Ther
Autori principali: Okeke, Constance O., Burstein, Eitan S., Trubnik, Valerie, Deom, James E., Cooper, Michael S., Brinkley, Desirae A., Thimons, J. James, Kabiri, Alexander J., Gelb, Kerry M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7708554/
https://ncbi.nlm.nih.gov/pubmed/33034885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-020-00307-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi